Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric cancer who previously treated with first-line nivolumab plus chemotherapy

被引：0
|
作者：
Jeon, Youngkyung
Jeong, Sun Young
Jang, Jaeyeon
Jung, Ye Ji
Choi, Daeho
Hong, Joohyun
Kim, Seung Tae
Kang, Won Ki
Lee, Jeeyun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6756
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6756
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The role of ramucirumab plus paclitaxel as second-line therapy after failure of nivolumab plus doublet chemotherapy in patients with advanced gastric cancer
    Jeon, Youngkyung
    Lim, Sung Hee
    Lee, Jeeyun
    Kang, Won Ki
    Jang, Jae Yeon
    Jeong, Sun Young
    Choi, Daeho
    Kim, Seung Tae
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (06) : 2346 - 2353
  • [2] Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer
    Kadowaki, S.
    Izawa, N.
    Minashi, K.
    Nishina, T.
    Yamanaka, T.
    Muro, K.
    Sunakawa, Y.
    Hironaka, S.
    Kajiwara, T.
    Kawakami, Y.
    Nakajima, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [3] Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
    Nakajima, Takako Eguchi
    Kadowaki, Shigenori
    Minashi, Keiko
    Nishina, Tomohiro
    Yamanaka, Takeharu
    Hayashi, Yuichiro
    Izawa, Naoki
    Muro, Kei
    Hironaka, Shuichi
    Kajiwara, Takeshi
    Kawakami, Yutaka
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1029 - 1036
  • [4] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [5] Ramucirumab plus paclitaxel as a second-line treatment for advanced gastric or gastro-oesophageal junction cancer
    [J]. Nature Reviews Gastroenterology & Hepatology, 2014, 11 (11) : 642 - 642
  • [6] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    [J]. Investigational New Drugs, 2020, 38 : 533 - 540
  • [7] Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)
    Sato, Sho
    Kunisaki, Chikara
    Tamura, Yuko
    Yago, Akikazu
    Kasahara, Kohei
    Sato, Tsutomu
    Kondo, Hiroki
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Endo, Itaru
    [J]. ANTICANCER RESEARCH, 2023, 43 (12) : 5663 - 5669
  • [8] Efficacy and safety of nab-paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment for patients with advanced gastric cancer: A single institutional experience
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Shitara, Kohei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [9] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    [J]. BMC Cancer, 20
  • [10] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    [J]. BMC CANCER, 2020, 20 (01)
12345